Company information
- Ticker
- CCRN
- Country
- United States
- Sector
- Health Care
- Industry
- Providers
CROSS COUNTRY HEALTHCARE Business Summary
Cross Country Healthcare (CCRN) operates a tech-enabled human capital management model, generating revenue primarily through billable hourly rates for temporary and permanent healthcare staffing. The company’s business is divided into two core segments: Nurse and Allied Staffing, which provides travel and local nursing and allied health professionals, and Physician Staffing, which offers locum tenens services across various medical specialties. CCRN increasingly leverages a Managed Service Program (MSP) and Recruitment Process Outsourcing (RPO) framework to provide comprehensive workforce solutions to health systems, having secured over $400 million in contract value in late 2025. In the competitive landscape, CCRN is a top-tier national provider alongside AMN Healthcare Services, Aya Healthcare, and CHG Healthcare. While it has faced industry-wide post-pandemic normalization, CCRN maintains a strong market position by differentiating through its proprietary "Intellify" vendor-neutral platform and a growing focus on the homecare staffing sector. The leadership team is currently led by Co-Founder, Chairman, and CEO Kevin C. Clark, who returned to the chief executive role in December 2025 to spearhead an AI-led growth strategy following the departure of John A. Martins. Clark, who originally co-founded the firm in 1986, brings nearly four decades of industry pedigree, including previous successful tenures as CEO during periods of rapid expansion. He is supported by Executive Vice President and CFO William J. Burns, who oversees financial strategy, and Chief Solutions & Operating Officer Amiee Hawkins, who unifies enterprise strategy across sales and product operations. The company’s board includes Lead Independent Director Larry Cash and notable figures such as Janice E. Nevin, MD. CCRN remains a publicly traded entity with significant institutional backing from major investors including BlackRock, The Vanguard Group, and Dimensional Fund Advisors.